Amin Sharifan, PharmD

Abdulazeem, H.; Borges do Nascimento, I.J.; Weerasekara, I.; Sharifan, A.; Grandi Bianco, V.; Cunningham, C.; Kularathne, I.; Deeken, G.; de Barros, J.; Sathian, B.; Østengaard, L.; Lamontagne-Godwin, F.; van Hoof, J.; Lazeri, L.; Redlich, C.; Marston, H.R.; Alistair Dos Santos, R.; Azzopardi-Muscat, N.; Yon, Y.; Novillo-Ortiz, D. (2025). Use of Digital Health Technologies for Dementia Care: Bibliometric Analysis and Report. JMIR Ment Health, 12:e64445: 10.2196/64445

Feigin, V. L. ; Vos, T.; Nair, B. S.; Hay, S. I.; Abate, Y. H.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, 10: e203-27

GBD 2021 Europe Life Expectancy Collaborators; Steel, N., Sharifan, A. (2025). Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. Lancet Public Health, 10: e172–88

GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators (2025). Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage. The Global Burden of Disease Study 2021. JAMA Neurology, 10.1001/jamaneurol.2025.1522: E1-E23

GBD 2021 Suicide Collaborators; Davis Weaver, N.; Sharifan, A.; (2025). Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Public Health, 10: e189-e202

Haeuser, E.; Byrne, S.; Nguyen, J.; Raggi, C.; McLaughlin, S.A.; Bisignano, C.; et al. Sharifan, A: (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10500: 235-260

Kerr, J. A.; Patton, G. C.; Cini, K. I.; Abate, Y. H.; Abbas, N.; Abd Al Magied, A. H. A.; et al. (2025). Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 785-812

Li, S.; Zhang, L.; Wang, Y.; Xie, R.; Chen, W.; Soo Lee, M.; Amer, Y.S.; Sharifan, A.; Hussein, H.; Li, H. (2025). Development and validation a methodology model for traditional Chinese medicine good practice recommendation: an exploratory sequential mixed methods study. Frontiers in Pharmacology, 16:1501634: 10.3389/fphar.2025.1501634

M. Ng,; E. Gakidou,; J. Lo,; Y. H. Abate,; C. Abbafati,; N. Abbas,; et al. (2025). Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet, 405: 813-38

Nevill, C.R.; Sharifan, A.; O'Mahony, A.; Tahir, H.; Robinson, W.; Modha, U.; Kahale, L.A.; Khamis, A.M.; Akl, E.A.; Smith, E.A.; Sutton, A.J.; Freeman, S.C.; Cooper, N.J. (2025). Capturing the influx of living systematic reviews: a systematic methodological survey. Journal of Clinical Epidemiology, 186: 111904

Oh, J.; Kim, S.; Kim, M. S.; Abate, Y. H.; Abd ElHafeez, S.; Abdelkader, A.; et al. (2025). Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine, 13, 5: 425-446

Rafferty, Q.; Stafford, L.K.; Vos, T.; Thomé, F.S.; Aalruz, H.; Abate, Y.H.; et al. Sharifan, A.; (2025). Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, Vol. 13 Issue 8: e1378-e1395

S. Lee, Y. Son, J. Hwang, M. S. Kim, J. I. Shin, N. J. Kassebaum, et al. (2025). Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nature Medicine, https://doi.org/10.1038/s41591-025-03624-8: https://doi.org/10.1038/s41591-025-03624-8

Sharifan, A. (2025). Oncolytic Virotherapy in Otorhinolaryngologic Neoplasms: A Scoping Review and Bibliometric Analysis. American Journal of Therapeutics, 10.1097/MJT.0000000000001876: 10.1097/MJT.0000000000001876

Sharifan, A. (2025). Bridging knowledge gaps in phytotherapy for a neglected zoonotic disease: Rift valley fever. Biomedicine & Pharmacotherapy, 187: https://doi.org/10.1016/j.biopha.2025.118092

Sharifan, A. (2025). Natural Compounds against Mpox: Mapping Evidence and Identifying Gaps. Planta Med, 91: 271-273

Sharifan, A. (2025). From “No Difference” to “Trending”: misinterpretation of statistical analysis in animal studies. Naunyn-Schmiedeberg's Archives of Pharmacology, https://doi.org/10.1007/s00210-025-04440-0: https://doi.org/10.1007/s00210-025-04440-0

Sharifan, A. (2025). Navigating the grey area: “Trend” statements to report statistical findings in the critical care literature. Journal of Critical Care, 89: 155162

Sharifan, A.; Abdulazeem, H.; Meckawy, R.; Sonkoue Pianta, M.; Abdelwahab, M.M.; Halder, A.; Gust Duque, T.; (2025). Appraisal of World Health Organization guidelines for priority infectious diseases with potential to cause public health emergencies. Public Health, 240: 112-118

Sharifan, A.; Fonarow, G. (2025). Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials. Heart, Online first: 10.1136/heartjnl-2025-326515